Topics

Highly Potent APIs 2019 Conference

14:15 EDT 2 May 2019 | World Pharma News

SMi Group13 - 14 May 2019, London, UK.
The HPAPI global market has developed rapidly in the past year and is continuing to expand into the future, with over a quarter of drugs in development worldwide being classified as highly potent. As a result, there is a growing demand for both pharmaceutical and contracted manufacturers to adapt to the evolving HPAPI landscape.

Original Article: Highly Potent APIs 2019 Conference

NEXT ARTICLE

More From BioPortfolio on "Highly Potent APIs 2019 Conference"

Quick Search